Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Suisse (CSUI) Cash & Equivalents (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed Cash & Equivalents for 9 consecutive years, with $2625.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 35.98% to $2625.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $2625.0, a 35.98% decrease, with the full-year FY2025 number at $2850.0, down 90.02% from a year prior.
  • Cash & Equivalents was $2625.0 for Q4 2025 at Cannabis Suisse, up from $305.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $38339.0 in Q4 2022 to a low of $44.0 in Q1 2024.
  • A 4-year average of $8828.6 and a median of $2850.0 in 2025 define the central range for Cash & Equivalents.
  • Biggest YoY gain for Cash & Equivalents was 14252.76% in 2024; the steepest drop was 99.13% in 2024.
  • Cannabis Suisse's Cash & Equivalents stood at $38339.0 in 2022, then plummeted by 85.8% to $5444.0 in 2023, then decreased by 24.69% to $4100.0 in 2024, then plummeted by 35.98% to $2625.0 in 2025.
  • Per Business Quant, the three most recent readings for CSUI's Cash & Equivalents are $2625.0 (Q4 2025), $305.0 (Q3 2025), and $2850.0 (Q2 2025).